List of Excipients in API mitotane
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mitotane
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
ER Squibb & Sons LLC | LYSODREN | mitotane | 0015-3080 | CELLULOSE, MICROCRYSTALLINE | |
ER Squibb & Sons LLC | LYSODREN | mitotane | 0015-3080 | POLYETHYLENE GLYCOL 3350 | |
ER Squibb & Sons LLC | LYSODREN | mitotane | 0015-3080 | SILICON DIOXIDE | |
HRA Pharma Rare Diseases | LYSODREN | mitotane | 76336-080 | CELLULOSE, MICROCRYSTALLINE | |
HRA Pharma Rare Diseases | LYSODREN | mitotane | 76336-080 | POLYETHYLENE GLYCOL 3350 | |
HRA Pharma Rare Diseases | LYSODREN | mitotane | 76336-080 | SILICON DIOXIDE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for mitotane
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mitotane drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | mitotane | 0015-3080 |
HRA Pharma Rare Diseases | mitotane | 76336-080 |
>Company | >Ingredient | >NDC |
mitotane drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
mitotane drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | mitotane | 0015-3080 |
HRA Pharma Rare Diseases | mitotane | 76336-080 |
>Company | >Ingredient | >NDC |
mitotane drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
mitotane drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | mitotane | 0015-3080 |
HRA Pharma Rare Diseases | mitotane | 76336-080 |
>Company | >Ingredient | >NDC |
mitotane drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
mitotane drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
HRA Pharma Rare Diseases | mitotane | 76336-080 |
>Company | >Ingredient | >NDC |
mitotane drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | mitotane | 0015-3080 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.